BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 22, 2000
View Archived Issues
Antisoma makes significant progress in product pipeline
Read More
Thalidomide improves tolerability of irinotecan in colorectal cancer patients
Read More
Genta presents clinical trial update for Genasense
Read More
Genzyme General's BLA for Fabry's disease accepted by FDA
Read More
Study of pulmonary delivery of patented respiratory drug completed at Sheffield
Read More
Antex Pharma licenses new peptides to treat lung diseases
Read More
IntraDose receives orphan drug status for melanoma indication
Read More
Levaquin tablets/injection approved for new indication in U.S.
Read More
Synaptic broadens access to drug design technology
Read More
Pierre Fabre and bioMerieux to merge
Read More
Roche and BMS form alliance to study Herceptin/Taxol anticancer combination
Read More
Italian researchers present newly discovered 5alpha-reductase isoform 1-selective inhibitors
Read More
RP-60556A, a new topical antibacterial agent for Gram-positive infections
Read More
Baxter and Peptide Therapeutics enter collaboration for vaccine development
Read More
Fluticasone more effective than montelukast in asthma control
Read More
Korean carbapenem compares favorably to meropenem regarding antibacterial activity, safety
Read More
New inhibitors of beta-amyloid fibril formation reported by Novartis
Read More
Two recently issued patents cover Pfizer's new PTK inhibitors
Read More
Neurotrophic agents with novel profile designed at Schering AG
Read More
Shionogi presents new MMP inhibitors with cyclic structure
Read More
Factor Xa inhibitors synthesized and tested at AstraZeneca
Read More
Preparation and use of new compounds inhibiting fat accumulation described by Sumitomo
Read More
Novel calcilytic compounds useful for bone disorders
Read More
Spectrum of new ketolide includes susceptible and resistant respiratory tract pathogens
Read More
Chiron takes first step towards merger with PathoGenesis
Read More